Stay updated with breaking news from Vaxx Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imugene Ltd (ASX:IMU, OTC:IUGNF) is preparing 10 clinical trial sites in Australia and the UK for a new PD1-Vaxx Phase 2 colorectal (CRC) cancer clinical...
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia and the UK for a new...
The Australian sharemarket was up today, gaining 125.30 points or 1.77% to 7,186.90 and setting a new 50-day high. Mining stocks were prominent, with the...
Imugene Ltd (ASX:IMU, OTC:IUGNF) has presented findings from its PD1-Vaxx trial in non-small cell lung cancer patients at the International Association for...